| Authors: |
Walker EG; Elizabeth G. Walker, PhD, is the Director of Regulatory Strategy and Submissions at the Critical Path Institute in Tucson, AZ. Amanda F. Baker, PharmD, PhD, is an Associate Professor of Medicine at the University of Arizona Cancer Center and a Research Scientist at the Critical Path Institute, both in Tucson, AZ. John-Michael Sauer, PhD, is the Executive Director of the Predictive Safety Testing Consortium at the Critical Path Institute in Tucson, AZ., Baker AF; Elizabeth G. Walker, PhD, is the Director of Regulatory Strategy and Submissions at the Critical Path Institute in Tucson, AZ. Amanda F. Baker, PharmD, PhD, is an Associate Professor of Medicine at the University of Arizona Cancer Center and a Research Scientist at the Critical Path Institute, both in Tucson, AZ. John-Michael Sauer, PhD, is the Executive Director of the Predictive Safety Testing Consortium at the Critical Path Institute in Tucson, AZ., Sauer JM; Elizabeth G. Walker, PhD, is the Director of Regulatory Strategy and Submissions at the Critical Path Institute in Tucson, AZ. Amanda F. Baker, PharmD, PhD, is an Associate Professor of Medicine at the University of Arizona Cancer Center and a Research Scientist at the Critical Path Institute, both in Tucson, AZ. John-Michael Sauer, PhD, is the Executive Director of the Predictive Safety Testing Consortium at the Critical Path Institute in Tucson, AZ. |
